APA (7th ed.) Citation

Raschzok, N., Stintzing, S., Heinemann, V., Rauch, G., Ricke, J., Guckenberger, M., . . . Modest, D. P. (2022). FIRE-9 – PORT / AIO-KRK-0418: A prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer. BMC cancer, 22(1), 359-9. https://doi.org/10.1186/s12885-022-09422-6

Chicago Style (17th ed.) Citation

Raschzok, Nathanael, et al. "FIRE-9 – PORT / AIO-KRK-0418: A Prospective, Randomized, Open, Multicenter Phase III Trial to Investigate the Efficacy of Adjuvant/additive Chemotherapy in Patients with Definitely-treated Metastatic Colorectal Cancer." BMC Cancer 22, no. 1 (2022): 359-9. https://doi.org/10.1186/s12885-022-09422-6.

MLA (9th ed.) Citation

Raschzok, Nathanael, et al. "FIRE-9 – PORT / AIO-KRK-0418: A Prospective, Randomized, Open, Multicenter Phase III Trial to Investigate the Efficacy of Adjuvant/additive Chemotherapy in Patients with Definitely-treated Metastatic Colorectal Cancer." BMC Cancer, vol. 22, no. 1, 2022, pp. 359-9, https://doi.org/10.1186/s12885-022-09422-6.